Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224633 · ClinicalTrials.gov registry record · NA
A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin
A NA study of Acne Vulgaris, sponsored by Kenvue Brands.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT07224633 is a NA study of Acne Vulgaris that has completed, run by Kenvue Brands. The registered enrollment target is 47 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07224633, a NA study of Acne Vulgaris, has completed, sponsored by Kenvue Brands.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the tolerance and efficacy of a facial moisturizer in subjects with mild to moderate acne vulgaris over a 4-week treatment period.
Conditions Studied
Interventions
- OTHER Use of Barrier Building Moisturizer
Study Locations (1)
New Jersey
- TKL Research Inc. - Fair Lawn - Fair Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2025-10-07 |
| Est. Completion | 2025-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07224633
The ClinicalTrials.gov registry entry for NCT07224633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (83% lower). The listed sponsor is Kenvue Brands, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Use of Barrier Building Moisturizer is the first listed.
NCT07224633 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07224633 about?
NCT07224633 is a clinical study titled "A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin". The objective of this study is to evaluate the tolerance and efficacy of a facial moisturizer in subjects with mild to moderate acne vulgaris over a 4-week treatment period.
What is the current status of trial NCT07224633?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2025-10-07. Estimated completion is 2025-12-16.
What conditions does trial NCT07224633 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT07224633?
The interventions under investigation include: Use of Barrier Building Moisturizer (OTHER).
Who is sponsoring clinical trial NCT07224633?
This trial is sponsored by Kenvue Brands, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224633 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Laser Treatment of Moderate to Severe Acne Vulgaris
ACTIVE NOT RECRUITING · NA
-
A Post Market Device Study for the Treatment of Acne
ACTIVE NOT RECRUITING · NA
-
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone
COMPLETED · NA
-
Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris
COMPLETED · NA
-
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
COMPLETED · NA
-
A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.